A Closer Look At Abcam plc's (LON:ABC) Uninspiring ROE

One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will work through how we can use Return On Equity (ROE) to better understand a business. We'll use ROE to examine Abcam plc (LON:ABC), by way of a worked example.

Abcam has a ROE of 16%, based on the last twelve months. That means that for every £1 worth of shareholders' equity, it generated £0.16 in profit.

Check out our latest analysis for Abcam

Advertisement

How Do You Calculate ROE?

The formula for ROE is:

Return on Equity = Net Profit ÷ Shareholders' Equity

Or for Abcam:

16% = UK£58m ÷ UK£367m (Based on the trailing twelve months to December 2018.)

Most know that net profit is the total earnings after all expenses, but the concept of shareholders' equity is a little more complicated. It is all the money paid into the company from shareholders, plus any earnings retained. You can calculate shareholders' equity by subtracting the company's total liabilities from its total assets.

What Does ROE Signify?

ROE measures a company's profitability against the profit it retains, and any outside investments. The 'return' is the profit over the last twelve months. The higher the ROE, the more profit the company is making. So, all else being equal, a high ROE is better than a low one. That means it can be interesting to compare the ROE of different companies.

Does Abcam Have A Good Return On Equity?

By comparing a company's ROE with its industry average, we can get a quick measure of how good it is. Importantly, this is far from a perfect measure, because companies differ significantly within the same industry classification. As is clear from the image below, Abcam has a lower ROE than the average (22%) in the Biotechs industry.

AIM:ABC Past Revenue and Net Income, July 31st 2019
AIM:ABC Past Revenue and Net Income, July 31st 2019

That's not what we like to see. We prefer it when the ROE of a company is above the industry average, but it's not the be-all and end-all if it is lower. Still, shareholders might want to check if insiders have been selling.

How Does Debt Impact Return On Equity?

Most companies need money -- from somewhere -- to grow their profits. That cash can come from retained earnings, issuing new shares (equity), or debt. In the first and second cases, the ROE will reflect this use of cash for investment in the business. In the latter case, the use of debt will improve the returns, but will not change the equity. Thus the use of debt can improve ROE, albeit along with extra risk in the case of stormy weather, metaphorically speaking.

Abcam's Debt And Its 16% ROE

Abcam is free of net debt, which is a positive for shareholders. Its ROE already suggests it is a good business, but the fact it has achieved this -- and doesn't borrowings -- makes it worthy of further consideration, in my view. After all, when a company has a strong balance sheet, it can often find ways to invest in growth, even if it takes some time.

The Key Takeaway

Return on equity is one way we can compare the business quality of different companies. In my book the highest quality companies have high return on equity, despite low debt. If two companies have around the same level of debt to equity, and one has a higher ROE, I'd generally prefer the one with higher ROE.

But ROE is just one piece of a bigger puzzle, since high quality businesses often trade on high multiples of earnings. The rate at which profits are likely to grow, relative to the expectations of profit growth reflected in the current price, must be considered, too. So you might want to take a peek at this data-rich interactive graph of forecasts for the company.

Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.

About AIM:ABC

Abcam

Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery.

Excellent balance sheet and good value.

Advertisement

Weekly Picks

CE
Ceazar
GOAI logo
Ceazar on Eva Live ·

This small cap is building the AI workforce of the future

Fair Value:US$7.4351.3% undervalued
77 users have followed this narrative
0 users have commented on this narrative
16 users have liked this narrative
TR
tripledub
LULU logo
tripledub on lululemon athletica ·

Lululemon Got Boring Right About the Time It Got Cheap. That's Usually the Point

Fair Value:US$22042.4% undervalued
26 users have followed this narrative
6 users have commented on this narrative
27 users have liked this narrative
WO
woodworthfund
KHC logo
woodworthfund on Kraft Heinz ·

Kraft Heinz (KHC): Less Drama, More Ketchup

Fair Value:US$3532.7% undervalued
8 users have followed this narrative
0 users have commented on this narrative
2 users have liked this narrative
CA
Canderous
TAL logo
Canderous on PetroTal ·

Beyond 2026, Beyond a Double

Fair Value:CA$1.8168.5% undervalued
27 users have followed this narrative
0 users have commented on this narrative
3 users have liked this narrative

Updated Narratives

BR
CMPI logo
Bradders3 on CT Global Managed Portfolio Trust ·

Neat way of diversifying

Fair Value:UK£1.290% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
BR
BrandonM84
LWLG logo
BrandonM84 on Lightwave Logic ·

Pre Commercialization optimism

Fair Value:US$74.182.2% undervalued
8 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
AS
AstrisCorporateAdvisory
3676 logo
AstrisCorporateAdvisory on DIGITAL HEARTS HOLDINGS ·

Strategic pivot in maximizing corporate value

Fair Value:JP¥928.1618.0% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

GO
QS logo
GoldenSands on QuantumScape ·

QuantumScape: A Mispriced Deep‑Tech Inflection Point With Multi‑Billion‑Dollar Optionality

Fair Value:US$8590.1% undervalued
114 users have followed this narrative
2 users have commented on this narrative
31 users have liked this narrative
AN
AnalystConsensusTarget
NVDA logo
AnalystConsensusTarget on NVIDIA ·

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026

Fair Value:US$268.6118.3% undervalued
1195 users have followed this narrative
7 users have commented on this narrative
34 users have liked this narrative
TR
tripledub
LULU logo
tripledub on lululemon athletica ·

Lululemon Got Boring Right About the Time It Got Cheap. That's Usually the Point

Fair Value:US$22042.4% undervalued
26 users have followed this narrative
6 users have commented on this narrative
27 users have liked this narrative